Handelsbanken Fonder AB - DICERNA PHARMACEUTICALS INC ownership

DICERNA PHARMACEUTICALS INC's ticker is DRNA and the CUSIP is 253031108. A total of 178 filers reported holding DICERNA PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 0.31 and the average weighting 0.2%.

Quarter-by-quarter ownership
Handelsbanken Fonder AB ownership history of DICERNA PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2021$363,000
-19.0%
18,000
+50.0%
0.00%0.0%
Q2 2021$448,000
+55.0%
12,000
+6.2%
0.00%0.0%
Q1 2021$289,000
+16.1%
11,3000.0%0.00%0.0%
Q4 2020$249,000
+22.7%
11,3000.0%0.00%
+100.0%
Q3 2020$203,000
-64.6%
11,300
-50.0%
0.00%
-50.0%
Q2 2020$574,00022,6000.00%
Other shareholders
DICERNA PHARMACEUTICALS INC shareholders Q3 2021
NameSharesValueWeighting ↓
Aquilo Capital Management, LLC 1,355,392$29,859,0006.21%
Bain Capital Life Sciences Investors, LLC 3,080,237$67,858,0004.26%
DAFNA Capital Management LLC 587,756$12,948,0003.85%
SILVERARC CAPITAL MANAGEMENT, LLC 227,388$5,009,0002.91%
RTW INVESTMENTS, LP 7,253,857$159,802,0002.68%
Parkman Healthcare Partners LLC 331,513$7,303,0001.87%
Evolutionary Tree Capital Management, LLC 60,864$1,341,0001.02%
Eagle Health Investments LP 69,000$1,520,0000.97%
Woodline Partners LP 1,358,796$29,934,0000.79%
Affinity Asset Advisors, LLC 40,000$881,0000.47%
View complete list of DICERNA PHARMACEUTICALS INC shareholders